Expression of BCL2 in BC is also controlled by miR-195, whose overexpression enhances the sensibility of BC cells to both chemo- and radio-therapy (Singh and Saini, 2012; Zhu et al., 2015). The gene discussed is BCL2; the disease is breast cancer.